Abstract
The Stent or Surgery Trial is a randomized, controlled trial comparing percutaneous coronary intervention with coronary artery bypass grafting (CABG) for patients with multivessel disease. Initial results at a median follow-up of 2 years showed a survival advantage for patients randomized to CABG. This article reports survival outcome at a median follow-up of 6 years.
Original language | English |
---|---|
Pages (from-to) | 381-8 |
Number of pages | 8 |
Journal | Circulation |
Volume | 118 |
Issue number | 4 |
DOIs | |
Publication status | Published - 22 Jul 2008 |
Keywords
- Aged
- Angina Pectoris
- Angioplasty, Balloon, Coronary
- Coronary Artery Bypass
- Coronary Artery Disease
- Diabetes Mellitus
- Disease Progression
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Proportional Hazards Models
- Survival Rate